Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jimsenior


T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pfizer response to questions on M&A -> add value to company

DNK either. I have considered that a collaboration might be in the making...

October 21, 2022

T.ONC

RE:Simply Wealthy

Correction   -  Simply Wall Street

October 21, 2022

T.ONC

Simply Wealthy

A report out today. I have no opinion on what I have read of it.

October 21, 2022

T.ONC

RE:RE:RE:RE:Companies now seek to moderate TME to expand PD-(L)1 effect

One last question to myself. As a biomarker in PDAC I think a low expression...

October 19, 2022

T.ONC

RE:RE:RE:Companies now seek to moderate TME to expand PD-(L)1 effect

Yes. You are right. Just for fun (and sometimes just searching words brings...

October 19, 2022

T.ONC

RE:Companies now seek to moderate TME to expand PD-(L)1 effect

A  very interesting article admtting that PD-1/PD-L1 is not enough. CD8...

October 19, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:EY sees bolt-ons in the single to double digit billions now

Yes. Well said. I stumbled across the following this afternoon, and whilst...

October 13, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Biotech buyouts.

Yes. Thank you. Royalty was the word I was looking for. I heard that somehow...

October 10, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Biotech buyouts.

Not me. Just asking questions. A few of us would like to know what is behind...

October 10, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Biotech buyouts.

Thank you for explaining page 38. It is strange that AN appears not to be...

October 10, 2022

T.ONC

RE:RE:RE:RE:RE:RE:Biotech buyouts.

to Noteable, let me preface this by saying I do like reading your posts...

October 10, 2022

T.ONC

RE:RE:RE:RE:Biotech buyouts.

Page 38 of the August Presentation states  - Maintain rights in North...

October 10, 2022

T.ONC

RE:RE:Biotech buyouts.

There does seem to be a problem with the low share price given the promise of...

October 10, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:EY sees bolt-ons in the single to double digit billions now

to intho. I agree. This upcoming event should give us a few clues as to what&...

October 7, 2022

T.ONC

RE:RE:New results?

I think the following may address CPI alone with chemotherapy.. Search...

October 6, 2022

T.ONC

RE:RE:RE:Presentation in november

Look under media, press releases. It is there.

October 5, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Adlai Nortye

In re AN. After thinking about this, it is quite possible that AN is not...

October 4, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Adlai Nortye

Yes. I was thinking that this needs to be neatly tied together, and perhaps...

October 4, 2022

T.ONC

RE:AN

Someone on yahoo is again questioning the interest of AN in pela. Certainly...

October 4, 2022

T.ONC

RE:RE:RE:RE:Adlai Nortye

Yes. I see your point about a change. Perhaps when they stopped recruiting or...

September 28, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 Next

Featured Company